Pituitary corticotroph adenoma in a woman with long-standing Addison's disease: A histologic, immunocytochemical, electron microscopic, and in situ hybridization study

Endocrine Pathology

Volumn 7, Issue 1, 1996, Pages 91-97

  Kovacs, Kalman ^a   Stefaneanu, Lucia ^a   Horvath, Eva ^a   Buchfelder, Michael ^b   Fahlbusch, Rudolph ^b   Althoff, Peter H ^c   Moore, Christine ^a,b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c Bürgerhospital Frankfurt ^*  (Germany)

Author keywords

Addison's disease; Morphology; Pituitary; Pituitary disease; Pituitary neoplasm

Indexed keywords

EID: 26644431847     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02739919     Document Type: Article

References (24)

1. Krieger DT, Gewirtz GD. The nature of the circadian periodicity and suppressibility of immunoreactive ACTH levels in Addison's disease. J Clin Endocrinol Metab 39:46-52, 1974.
2. Scott RS, Donald RA, Espiner EA. Plasma ACTH and cortisol profiles in Addisonian patients receiving conventional substitution therapy. Clin Endocrinol 9:571-576, 1978.
3. Feek CM, Ratcliffe JG, Seth J, Gray CE, Toft AD, Irvine WJ. Patterns of plasma cortisol and ACTH concentrations in patients with Addison's disease treated with conventional corticosteroid replacement. Clin Endocrinol 14:451-458, 1981.
4. Dluhy RG, Moore TJ, Williams GH. Sella turcica enlargement and primary adrenal insufficiency. Ann Intern Med 89:513,514, 1978.
5. Carr DB, Fisher JE, Rosenblatt M. Response to low-dose pulsatile cortisol in Addison's disease with suspected corticotropinoma. Horm Metabol Res 18:569-573, 1986.
6. Mineura K, Goto T, Yoneya M, Kowada M, Tamakawa Y, Kagaya H. Case report: pituitary enlargement associated with Addison's disease. Clin Radiol 38:435-437, 1987.
7. Kubota T, Hayashi M, Kabuto M, Shirasaki N, Aradachi H, Miyanaga K, Miyabo S. Corticotroph cell hyperplasia in a patient with Addison disease: case report. Surg Neurol 37:441-447, 1992.
8. Clayton R, Burden AC, Schrieber V, Rosenthal FD. Secondary pituitary hyperplasia in Addison's disease. Lancet 2:954-956, 1977.
9. Himsworth RL, Lewis JG, Rees LH. A possible ACTH secreting tumour of the pituitary developing in a conventionally treated case of Addison's disease. Clin Endocrinol 9:131-139, 1978.
10. Jara-Albarran A, Bayort J, Caballero A, Portillo J, Laborda L, Sampedro M, Cure C, Palacios Mateos JM. Probable pituitary adenoma with adrenocorticotropin hypersecretion (corticotropinoma) secondary to Addison's disease. J Clin Endocrinol Metab 49:236-241, 1979.
11. Yanase T, Sekiya K, Ando M, Nawata H, Kato K, Ibayashi H. Probable ACTH-secreting pituitary tumour in association with Addison's disease. Acta Endocrinol 110:36-41, 1985.
12. Aanderud S, Bassoe HH. A pituitary tumor with possible ACTH and TSH hypersecretion in a patient with Addison's disease and primary hypothyroidism. Acta Endocrinol 95:181-184, 1980.
13. Krautli B, Muller J, Landolt AM, Schulthess von F. ACTH-producing pituitary adenomas in Addison's disease: two cases treated by transsphenoidal microsurgery. Acta Endocrinol 99:357-363, 1982.
14. Scheithauer BW, Kovacs K, Randall RV. The pituitary gland in untreated Addison's disease. A histologic and immunocytologic study of 18 adenohypophyses. Arch Pathol Lab Med 107:484-487, 1983.
15. Kovacs K, Lloyd R, Horvath E, Asa SL, Stefaneanu L, Killinger DW, Smyth HS. Silent somatotroph adenomas of the human pituitary. A morphologic study of three cases including immunocytochemistry, electron microscopy, in vitro examination, and in situ hybridization. Am J Pathol 134:345-353, 1989.
16. Kovacs K, Stefaneanu L, Horvath E, Lloyd RV, Lancranjan I, Buchfelder M, Fahlbusch R. Effect of dopamine agonist medication on prolactin producing pituitary adenomas. A morphological study including immunocytochemistry, electron microscopy and in situ hybridization. Virchows Arch Pathol Anat 418:439-446, 1991.
17. Stefaneanu L, Kovacs K, Horvath E, Lloyd RV. In situ hybridization study of pro-opiomelanocortin (POMC) gene expression in human pituitary corticotrophs and their adenomas. Virchows Arch Pathol Anat 419:107-113, 1991.
18. Doniach I. Histopathology of the pituitary. Clin Endocrinol Metab 14:765-789, 1985.
19. Gertz BJ, Contreras LN, McComb DJ, Kovacs K, Tyrrell JB, Dallman MF. Chronic administration of corticotropin-releasing factor increases pituitary corticotroph number. Endocrinology 120:381-388, 1987.
20. McNicol AM, Kubba MAG, McTeauge E. The mitogenic effects of corticotrophin releasing factor on the anterior pituitary of rats. J Endocrinol 118:237-241, 1988.
21. Asa SL, Kovacs K, Hammer GD, Liu B, Roow BA, Low MJ. Pituitary corticotroph hyperplasia in rats implanted with a medullary thyroid carcinoma cell line transfected with a corticotropin-releasing hormone complementary deoxyribonucleic acid expression vector. Endocrinology 131:715-720, 1992.
22. Childs GV, Rougeau D, Unabia G. Corticotropin-releasing hormone and epidermal growth factor: mitogens for anterior pituitary corticotropes. Endocrinology 136:1595-1602, 1995.
23. Leiba S, Landau B, Ber A. Target gland insufficiency and pituitary tumors. Acta Endocrinol 60:112-120, 1969.
24. Kleinberg DL. Pituitary tumors and failure of endocrine target organs. Arch Intern Med 139:969,970, 1979.